Hep C: an unnecessary epidemic

July 28 is World Hepatitis Day, and it’s fitting to remind ourselves that Canadians’ lives are imperiled unnecessarily by hepatitis C — stemming from a lack of knowledge about the disease and from barriers to gaining access to treatment. New research recently published in the Lancet indicates that "viral hepatitis is a leading cause of death and disability worldwide." In Canada, an estimated 330,000-plus people have been infected by hepatitis C; that’s ...

Merck ushers in price war for hepatitis C medicines with new drug

After two years of controversy over the cost of hepatitis C treatments, the fast-growing market is poised to undergo a price war.Late Thursday, Merck received Food and Drug Administration approval for its Zepatier medication and set a list price of just $54,600 for a 12-week course of treatment. This is considerably lower than the cost of rival medicines that have helped spark national outrage over prescription drug pricing.By comparison, the list price fo